Areas of Focus
- Tumor Angiogenesis and Anti-Cancer Drug Research
- Artificial Intelligence Pathology Diagnosis
- Tumor Stem Cells and Microenvironment
Work Experience
- 1989/7-1992/11 - Third Military Medical University - Assistant Lecturer
- 1992/12-1994/11 - Third Military Medical University - Lecturer
- 1994/12-1995/12 - Third Military Medical University - Associate Professor
- 1996/01-1999/08 - Third Military Medical University - Deputy Director, Associate Professor
- 1999/09-2001/08 - Third Military Medical University - Professor
- 2001/09-2006/06 - Third Military Medical University - Chief Physician, Professor
- 2006/07-2017/11 - Third Military Medical University - Department Head, Chief Physician, Professor
- 2017/12-present - Army Medical University - Department Head, Chief Physician, Professor
- 2011-present - Director of Key Laboratory of Pathology
- 2012-present - Director of Key Laboratory of Tumor Immunopathology
Academic Background & Achievements
- 1981/9-1986/7 Bachelor of Medicine: Third Military Medical University
- 1986/9-1989/7 Master of Medicine: Third Military Medical University
- 1991/9-1995/6 Doctor of Medicine: Third Military Medical University
- Published over 150 SCI papers in renowned journals like Nature, Science, Cell
Publications
- COVID-19-associated monocytic encephalitis (CAME): histological and proteomic evidence from autopsy, Zhang PP, He ZC, Yao XH, Tang R, Ma J, Luo T, Zhu C, Li TR, Liu X, Zhang D, Zhang S, Ping YF, Leng L, Bian XW, 2023
- Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas, Wang YX, Wu H, Ren Y, Lv S, Ji C, Xiang D, Zhang M, Lu H, Fu W, Liu Q, Yan Z, Ma Q, Miao J, Cai R, Lan X, Wu B, Wang W, Liu Y, Wang DZ, Cao M, He Z, Shi Y, Ping Y, Yao X, Zhang X, Zhang P, Wang JM, Wang Y, Cui Y, Bian XW, 2022
- EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma, Gai QJ, Fu Z, He J, Mao M, Yao XX, Qin Y, Lan X, Zhang L, Miao JY, Wang YX, Zhu J, Yang FC, Lu HM, Yan ZX, Chen FL, Shi Y, Ping YF, Cui YH, Zhang X, Liu X, Yao XH, Lv SQ, Bian XW, Wang Y, 2022
- ASCL2 Maintains stemness phenotype through ATG9B and sensitizes gliomas to autophagy inhibitor, Wang LH, Yuan Y, Wang J, Luo Y, Lan Y, Ge J, Li L, Liu F, Deng Q, Yan ZX, Liang M, Wei S, Liu XD, Wang Y, Ping YF, Shi Y, Yu SC, Zhang X, Cui YH, Yao XH, Feng H, Luo T, Bian XW, 2022
- SIRPγ-expressing cancer stem-like cells promote immune escape of lung cancer via Hippo signaling, Xu C, Jin G, Wu H, Cui W, Wang YH, Manne RK, Wang G, Zhang W, Zhang X, Han F, Cai Z, Pan BS, Hsu CC, Liu Y, Zhang A, Long J, Zou H, Wang S, Ma X, Duan J, Wang B, Liu W, Lan H, Xiong Q, Xue G, Chen Z, Xu Z, Furth ME, Haigh Molina S, Lu Y, Xie D, Bian XW, Lin HK, 2022
- A single-cell transcriptomic landscape of the lungs of patients with COVID-19, Wang S, Yao X, Ma S, Ping Y, Fan Y, Sun S, He Z, Shi Y, Sun L, Xiao S, Song M, Cai J, Li J, Tang R, Zhao L, Wang C, Wang Q, Zhao L, Hu H, Liu X, Sun G, Chen L, Pan G, Chen H, Li Q, Zhang P, Xu Y, Feng H, Zhao GG, Wen T, Yang Y, Huang X, Li W, Liu Z, Wang H, Wu H, Hu B, Ren Y, Zhou Q, Qu J, Zhang W, Liu GH, Bian XW, 2021
- Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling, Zhang XN, Yang KD, Chen C, He ZC, Wang QH, Feng H, Lv SQ, Wang Y, Mao M, Liu Q, Tan YY, Wang WY, Li TR, Che LR, Qin ZY, Wu LX, Luo M, Luo CH, Liu YQ, Yin W, Wang C, Guo HT, Li QR, Wang B, Chen W, Wang S, Shi Y, Bian XW, Ping YF, 2021
Awards
- National Science and Technology Progress Award (2012): First Prize
- Chinese Medical Science Award (2011): First Prize
- China Anti-Cancer Association Science Award (2010): First Prize
- Chongqing Natural Science Award (2010): First Prize
- Chongqing Natural Science Award (2008): First Prize
- Military Science and Technology Progress Award (1999): Second Prize
- Ho Leung Ho Lee Foundation Science and Technology Progress Award (2014): Science and Technology Progress Award